Michael Kinch was a professor at Purdue University, where he researched breast and prostate cancer. He then went on to found an oncology program at the biotechnology company MedImmune. He has led drug discovery at Yale Universit and is now a professor and Vice Chancellor at Washington University in St. Louis. He is the author of Between Hope and Fear: A HIstory of Vaccines and Human Immunity; The End of the Beginning: Cancer, Immunity and the Future of a Cure, both available from Pegasus Books, and A Prescription for Change (UNC Press).
Lori Weiman is the Principal and Founder of Weiman Strategic Advisers, LLC, and has established productive public-private partnerships with trade associations, advocacy groups, non- profit organizations, academia and governmental agencies.